Table 1 Demographic and baseline clinical characteristics of the patients with MPP
Characteristics | Total (n = 63) | non-PB (n = 42) | PB (n = 21) | P |
|---|---|---|---|---|
Sex (n, %) | 1.000 | |||
Male | 33 (52.4) | 22 (52.4) | 11 (52.4) | |
Female | 30 (52.4) | 20 (47.6) | 10 (47.6) | |
Age (y) | 7.7 (6.7–8.9) | 7.7 (6.7–9.0) | 7.7 (6.6–8.9) | 0.793 |
CRP (mg/L) | 9.5 (4.8–25.3) | 8.0 (3.2–18.8) | 23.8 (6.8–57.1) | 0.022 |
WBC (×109/L) | 10.5 (8.1–12.7) | 9.3 (7.3–11.3) | 14.0 (12.1–17.2) | < 0.001 |
Neutrophils (×109/L) | 7.1 (5.0–10.3) | 6.0 (4.5–8.2) | 11.5 (9.3–13.5) | < 0.001 |
Hemoglobin (g/L) | 127.0 (12.5–134.0) | 128.5 (122.0–135.8) | 126.0 (120.3–132.8) | 0.240 |
Platelets (×109/L) | 298.0 (249.5–382.5) | 301.5 (261.3–398.3) | 284.0 (204.3–327.3) | 0.232 |
ALT (U/L) | 19.0 (13.0–51.0) | 16.0 (13.0–32.5) | 31.0 (16.5–79.8) | 0.025 |
AST (U/L) | 25.0 (20.0–36.5) | 24.0 (20.8–33.0) | 27.0 (19.0–51.3) | 0.593 |
LDH (U/L) | 325.0 (266.5–475.5) | 303.5 (261.8–412.3) | 403.0 (321.3–726.8) | 0.007 |
PT (s) | 12.3 (11.6–13.1) | 11.9 (11.3–13.2) | 12.9 (11.9–13.1) | 0.105 |
APTT (s) | 30.1 (27.5–33.4) | 30.4 (27.6–32.8) | 29.9 (27.2–33.6) | 0.971 |
Fibrinogen (g/L) | 3.4 (2.8–3.7) | 3.3 (2.8–3.7) | 3.4 (3.0–3.8) | 0.255 |
D-dimer (ng/ml) | 328.0 (179.5–2122.5) | 271.5 (159.0–894.8) | 2430.5 (279.3–3443.8) | 0.001 |
Course of disease before admission (d) | 10.0 (8.0–12.0) | 10.0 (7.8–12.0) | 10.0 (8.0–12.8) | 0.697 |
Fever time before admission (d) | 9.0 (6.0–10.0) | 7.5 (6.0–10.0) | 9.5 (7.0–11.5) | 0.103 |
Course of disease before bronchoscopy (d) | 12.0 (10.0–15.5) | 12.0 (11.0–15.0) | 12.0 (10.3–16.8) | 0.959 |
Serosal effusion (n, %) | 0.002 | |||
Yes | 19 (30.2) | 7 (16.7) | 12 (57.1) | |
No | 44 (69.8) | 35 (83.3) | 9 (42.9) | |
PB position (n, %) | ||||
Right upper | 2 (9.5) | |||
Right middle | 1 (4.8) | |||
Right lower | 5 (23.8) | |||
Right main bronchus | 1 (4.8) | |||
Left upper | 3 (14.5) | |||
Right lower | 9 (42.9) |